Poll: AIDS and U.S. drugmakers

With Johnson & Johnson's decision not to participate in a program providing cheaper AIDS drugs in poor nations, a public debate has been restarted on the best way to achieve the same goal. Where do you stand?


Should U.S. drug firms find a way to provide low-cost AIDS drugs to poor nations?

Cast your vote now.